According to Divis Laboratories's latest financial reports the company has $0.43 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.50 B | 39.28% |
2022-03-31 | $0.36 B | 27.37% |
2021-03-31 | $0.28 B | 108.72% |
2020-03-31 | $0.13 B | -33.09% |
2019-03-31 | $0.20 B | -30.87% |
2018-03-31 | $0.29 B | 15.36% |
2017-03-31 | $0.25 B | 104.43% |
2016-03-31 | $0.12 B | 2.97% |
2015-03-31 | $0.12 B | 40.05% |
2014-03-31 | $86.46 M | 11.68% |
2013-03-31 | $77.42 M | -20.4% |
2012-03-31 | $97.26 M | -27.97% |
2011-03-31 | $0.13 B | 3574.61% |
2010-03-31 | $3.67 M | 26.21% |
2009-03-31 | $2.91 M | -18.25% |
2008-03-31 | $3.56 M | -16.16% |
2007-03-31 | $4.24 M | 79.93% |
2006-03-31 | $2.36 M |